Journal
IMMUNITY
Volume 56, Issue 2, Pages 234-236Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2023.01.018
Keywords
-
Categories
Ask authors/readers for more resources
In this study, researchers isolated human monoclonal antibodies against two potential transmission-blocking vaccine candidates for malaria, Pfs48/45 and Pfs230, and identified the epitopes responsible for their transmission-reducing activity.
The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understand-ing of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available